Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Jon C. Ogg | Oct 18, 2013 at 9:30 AM EDT

pSivida, Alimera and Ariad Join Bio-Implosion Watch

ThinkstockBiotech and emerging health care technology companies both fit into a high-stake poker match on Wall Street. Investors can earn…

Paul Ausick | Oct 17, 2013 at 10:25 AM EDT

UnitedHealth Earnings OK, Outlook Disappoints

ThinkstockUnitedHealth Group Inc. (NYSE: UNH) reported third-quarter 2013 results before markets opened Thursday morning. The health insurance and benefits management…

Jon C. Ogg | Oct 17, 2013 at 9:45 AM EDT

Amarin Implosion: The Future Went from Promising to Doubtful

ThinkstockBiotech is a sector where investors know they are entering a high-stakes game of big risk and big reward. That…

Douglas A. McIntyre | Oct 17, 2013 at 6:44 AM EDT

Oreos Are as Addictive as Cocaine

ThinkstockSome good news for makers of cookies and candy. Recent research shows that Oreos are as addictive as cocaine. However, the companies…

Paul Ausick | Oct 15, 2013 at 8:35 AM EDT

Johnson & Johnson Growth Stalls

Wikimedia CommonsJohnson & Johnson (NYSE: JNJ) reported third-quarter 2013 results before markets opened Tuesday morning. The health care giant posted…

Jon C. Ogg | Oct 14, 2013 at 2:36 PM EDT

Is Inhalable Insulin Assured To Be Approved By The FDA?

ThinkstockIf you have followed the diabetes drug market for very long, chances are high that you have run across the…

Jon C. Ogg | Oct 14, 2013 at 12:00 PM EDT

Coronado Implodes over Crohn’s Failure, Future Now Uncertain

Jon OggInvesting in biotech and emerging pharmaceutical stocks comes with a huge risk and reward profile for investors. Some wins…

Trey Thoelcke | Oct 14, 2013 at 8:15 AM EDT

Jefferies Top Biotech Stocks to Buy

ThinkstockThe world of biotechnology investing is a constantly evolving and changing one. While disease for the most part does not…

Paul Ausick | Oct 10, 2013 at 7:30 AM EDT

The Economic Impact of Obamacare: What’s Missing

Thinkstock What’s Missing — October 21, 2013 The implementation of the health insurance exchanges that began on October 1 has…

Jon C. Ogg | Oct 9, 2013 at 9:45 AM EDT

FDA Hold on Ariad Kills $2 Billion in Value (Updated)

via Wikimedia CommonsAriad Pharmaceuticals Inc. (NASDAQ: ARIA) is getting crushed on Wednesday due to a clinical hold placed by the…

Jon C. Ogg | Oct 9, 2013 at 8:15 AM EDT

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown…

Jon C. Ogg | Oct 8, 2013 at 2:47 PM EDT

Market Take: Biotech Suffers Under Government Shutdown Too!

ThinkstockThe field of pharmaceuticals is very well established and often is considered to be a very defensive sector. As such,…

Jon C. Ogg | Oct 8, 2013 at 2:00 PM EDT

When Data Conflicts: Is the Malaria Vaccine Data Good or Bad?

ThinkstockA malaria vaccine is supposed to be a good thing. Right? Unfortunately that all depends. GlaxoSmithKline PLC (NYSE: GSK) currently…

Jon C. Ogg | Oct 8, 2013 at 9:45 AM EDT

Analysts Target 150% Upside in EnteroMedics Stock Price

ThinkstockEnteroMedics Inc. (NASDAQ: ETRM) may be a largely unknown microcap stock to most investors. The company is in the development…

Douglas A. McIntyre | Oct 2, 2013 at 6:30 AM EDT

Big Pharma and 100,000 Jobs at Risk

ThinkstockMerck & Co. (NYSE: MRK) announced it would rid itself of 8,500 workers, many of whom work in the big…

1 … 298 299 300 301 302 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

pSivida, Alimera and Ariad Join Bio-Implosion Watch

UnitedHealth Earnings OK, Outlook Disappoints

Amarin Implosion: The Future Went from Promising to Doubtful

Oreos Are as Addictive as Cocaine

Johnson & Johnson Growth Stalls

Is Inhalable Insulin Assured To Be Approved By The FDA?

Coronado Implodes over Crohn’s Failure, Future Now Uncertain

Jefferies Top Biotech Stocks to Buy

The Economic Impact of Obamacare: What’s Missing

FDA Hold on Ariad Kills $2 Billion in Value (Updated)

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

Market Take: Biotech Suffers Under Government Shutdown Too!

When Data Conflicts: Is the Malaria Vaccine Data Good or Bad?

Analysts Target 150% Upside in EnteroMedics Stock Price

Big Pharma and 100,000 Jobs at Risk

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

Health and Healthcare Articles

All Health and Healthcare Articles

pSivida, Alimera and Ariad Join Bio-Implosion Watch

UnitedHealth Earnings OK, Outlook Disappoints

Amarin Implosion: The Future Went from Promising to Doubtful

Oreos Are as Addictive as Cocaine

Johnson & Johnson Growth Stalls

Is Inhalable Insulin Assured To Be Approved By The FDA?

Coronado Implodes over Crohn’s Failure, Future Now Uncertain

Jefferies Top Biotech Stocks to Buy

The Economic Impact of Obamacare: What’s Missing

FDA Hold on Ariad Kills $2 Billion in Value (Updated)

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

Market Take: Biotech Suffers Under Government Shutdown Too!

When Data Conflicts: Is the Malaria Vaccine Data Good or Bad?

Analysts Target 150% Upside in EnteroMedics Stock Price

Big Pharma and 100,000 Jobs at Risk

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up